| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2002;105:816.)
© 2002 American Heart Association, Inc.
Clinical Investigation and Reports |
From CNR Institute of Clinical Physiology, Pisa, Italy (G.B., G.L., M.M., T.S., R.D.C.); Institute of Pathology, University of Siena, Siena, Italy (P.T.); G. dAnnunzio University, Chieti, Italy (R.D.C.); and College of Physicians and Surgeons, Columbia University, New York, NY (C.F., T.K., D.M.S., A.M.S.).
Correspondence to Raffaele De Caterina, MD, PhD, University Cardiology Division, G. dAnnunzio University of Chieti, Ospedale S Camillo de Lellis, Via Forlanini, 50, I66100 Chieti, Italy. E-mail rdecater{at}unich.it
Background The products of nonenzymatic glycation and oxidation of proteins, the advanced glycation end products (AGEs), form under diverse circumstances such as aging, diabetes, and kidney failure. Recent studies suggested that AGEs may form in inflamed foci, driven by oxidation or the myeloperoxidase pathway. A principal means by which AGEs alter cellular properties is through interaction with their signal-transduction receptor RAGE. We tested the hypothesis that interaction of AGEs with RAGE on endothelial cells enhances vascular activation.
Methods and Results AGEs, RAGE, vascular cell adhesion molecule-1, intercellular adhesion molecule-1, and E-selectin are expressed in an overlapping manner in human inflamed rheumatoid synovia, especially within the endothelium. In primary cultures of human saphenous vein endothelial cells, engagement of RAGE by heterogeneous AGEs or N
(carboxymethyl)lysinemodified adducts enhanced levels of mRNA and antigen for vascular cell adhesion molecule-1, intercellular adhesion molecule-1, and E-selectin. AGEs increased adhesion of polymorphonuclear leukocytes to stimulated endothelial cells in a manner reduced on blockade of RAGE.
Conclusions AGEs, through RAGE, may prime proinflammatory mechanisms in endothelial cells, thereby amplifying proinflammatory mechanisms in atherogenesis and chronic inflammatory disorders.
Key Words: cell adhesion molecules receptors endothelium inflammation vasculature
This article has been cited by other articles:
![]() |
M. E. Rubio-Ruiz, E. Diaz-Diaz, M. Cardenas-Leon, R. Arguelles-Medina, P. Sanchez-Canales, F. Larrea-Gallo, E. Soria-Castro, and V. Guarner-Lans Glycation does not modify bovine serum albumin (BSA)-induced reduction of rat aortic relaxation: The response to glycated and nonglycated BSA is lost in metabolic syndrome Glycobiology, July 1, 2008; 18(7): 517 - 525. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. C. Burckhardt, D. Gozal, E. Dayyat, Y. Cheng, R. C. Li, A. D. Goldbart, and B. W. Row Green Tea Catechin Polyphenols Attenuate Behavioral and Oxidative Responses to Intermittent Hypoxia Am. J. Respir. Crit. Care Med., May 15, 2008; 177(10): 1135 - 1141. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. P. Kihm, D. Wibisono, S. Muller-Krebs, F. Pfisterer, C. Morath, M. L. Gross, M. Morcos, Y. Seregin, A. Bierhaus, P. P. Nawroth, et al. RAGE expression in the human peritoneal membrane Nephrol. Dial. Transplant., May 13, 2008; (2008) gfn272v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Cai, J. C. He, L. Zhu, X. Chen, G. E. Striker, and H. Vlassara AGE-receptor-1 counteracts cellular oxidant stress induced by AGEs via negative regulation of p66shc-dependent FKHRL1 phosphorylation Am J Physiol Cell Physiol, January 1, 2008; 294(1): C145 - C152. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Moser, D. D. Desai, M. P. Downie, Y. Chen, S. F. Yan, K. Herold, A. M. Schmidt, and R. Clynes Receptor for Advanced Glycation End Products Expression on T Cells Contributes to Antigen-Specific Cellular Expansion In Vivo J. Immunol., December 15, 2007; 179(12): 8051 - 8058. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. de Leeuw, R. Graaff, R. de Vries, R. P. Dullaart, A. J. Smit, C. G. Kallenberg, and M. Bijl Accumulation of advanced glycation endproducts in patients with systemic lupus erythematosus Rheumatology, October 1, 2007; 46(10): 1551 - 1556. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Cai, J. C. He, L. Zhu, X. Chen, S. Wallenstein, G. E. Striker, and H. Vlassara Reduced Oxidant Stress and Extended Lifespan in Mice Exposed to a Low Glycotoxin Diet: Association with Increased AGER1 Expression Am. J. Pathol., June 1, 2007; 170(6): 1893 - 1902. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Zen, C. X.-J. Chen, Y.-T. Chen, R. Wilton, and Y. Liu Receptor for Advanced Glycation Endproducts Mediates Neutrophil Migration across Intestinal Epithelium J. Immunol., February 15, 2007; 178(4): 2483 - 2490. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cuccurullo, A. Iezzi, M. L. Fazia, D. De Cesare, A. Di Francesco, R. Muraro, R. Bei, S. Ucchino, F. Spigonardo, F. Chiarelli, et al. Suppression of Rage as a Basis of Simvastatin-Dependent Plaque Stabilization in Type 2 Diabetes Arterioscler. Thromb. Vasc. Biol., December 1, 2006; 26(12): 2716 - 2723. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Poliseno, A. Tuccoli, L. Mariani, M. Evangelista, L. Citti, K. Woods, A. Mercatanti, S. Hammond, and G. Rainaldi MicroRNAs modulate the angiogenic properties of HUVECs Blood, November 1, 2006; 108(9): 3068 - 3071. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fujita, H. Okuda, O. Tsukamoto, Y. Asano, Y. L. A. Hirata, J. Kim, T. Miyatsuka, S. Takashima, T. Minamino, H. Tomoike, et al. Blockade of Angiotensin II Receptors Reduces the Expression of Receptors for Advanced Glycation End Products in Human Endothelial Cells Arterioscler. Thromb. Vasc. Biol., October 1, 2006; 26(10): e138 - e139. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhong, S.-H. Li, S.-M. Liu, P. E. Szmitko, X.-Q. He, P. W.M. Fedak, and S. Verma C-Reactive Protein Upregulates Receptor for Advanced Glycation End Products Expression in Human Endothelial Cells Hypertension, September 1, 2006; 48(3): 504 - 511. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Goldin, J. A. Beckman, A. M. Schmidt, and M. A. Creager Advanced Glycation End Products: Sparking the Development of Diabetic Vascular Injury Circulation, August 8, 2006; 114(6): 597 - 605. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shoji, H. Koyama, T. Morioka, S. Tanaka, A. Kizu, K. Motoyama, K. Mori, S. Fukumoto, A. Shioi, N. Shimogaito, et al. Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes. Diabetes, August 1, 2006; 55(8): 2245 - 2255. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. J. Goldberg and H. M. Dansky Diabetic Vascular Disease: An Experimental Objective Arterioscler. Thromb. Vasc. Biol., August 1, 2006; 26(8): 1693 - 1701. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Huebschmann, J. G. Regensteiner, H. Vlassara, and J. E.B. Reusch Diabetes and Advanced Glycoxidation End Products. Diabetes Care, June 1, 2006; 29(6): 1420 - 1432. [Full Text] [PDF] |
||||
![]() |
T. Sato, N. Shimogaito, X. Wu, S. Kikuchi, S.-i. Yamagishi, and M. Takeuchi Toxic Advanced Glycation End Products (TAGE) Theory in Alzheimer's Disease American Journal of Alzheimer's Disease and Other Dementias, May 1, 2006; 21(3): 197 - 208. [Abstract] [PDF] |
||||
![]() |
Z. Zhou, D. Immel, C.-X. Xi, A. Bierhaus, X. Feng, L. Mei, P. Nawroth, D. M. Stern, and W.-C. Xiong Regulation of osteoclast function and bone mass by RAGE J. Exp. Med., April 17, 2006; 203(4): 1067 - 1080. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tedgui and Z. Mallat Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways Physiol Rev, April 1, 2006; 86(2): 515 - 581. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. De Caterina, A. Zampolli, S. Del Turco, R. Madonna, and M. Massaro Nutritional mechanisms that influence cardiovascular disease Am. J. Clinical Nutrition, February 1, 2006; 83(2): 421S - 426S. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Galkina and K. Ley Leukocyte Recruitment and Vascular Injury in Diabetic Nephropathy J. Am. Soc. Nephrol., February 1, 2006; 17(2): 368 - 377. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Schwenger, C. Morath, A. Salava, K. Amann, Y. Seregin, R. Deppisch, E. Ritz, A. Bierhaus, P. P. Nawroth, and M. Zeier Damage to the Peritoneal Membrane by Glucose Degradation Products Is Mediated by the Receptor for Advanced Glycation End-Products J. Am. Soc. Nephrol., January 1, 2006; 17(1): 199 - 207. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Goldschmidt-Clermont, M. A. Creager, D. W. Lorsordo, G. K.W. Lam, M. Wassef, and V. J. Dzau Atherosclerosis 2005: Recent Discoveries and Novel Hypotheses Circulation, November 22, 2005; 112(21): 3348 - 3353. [Full Text] [PDF] |
||||
![]() |
J. M. Bohlender, S. Franke, G. Stein, and G. Wolf Advanced glycation end products and the kidney Am J Physiol Renal Physiol, October 1, 2005; 289(4): F645 - F659. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Basta, G. Lazzerini, S. Del Turco, G. M. Ratto, A. M. Schmidt, and R. De Caterina At Least 2 Distinct Pathways Generating Reactive Oxygen Species Mediate Vascular Cell Adhesion Molecule-1 Induction by Advanced Glycation End Products Arterioscler. Thromb. Vasc. Biol., July 1, 2005; 25(7): 1401 - 1407. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Y. Chow, D. J. Nikolic-Paterson, E. Ozols, R. C. Atkins, and G. H. Tesch Intercellular Adhesion Molecule-1 Deficiency Is Protective against Nephropathy in Type 2 Diabetic db/db Mice J. Am. Soc. Nephrol., June 1, 2005; 16(6): 1711 - 1722. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Ross RE: "Carbohydrate Intake, Glycemic Index, Glycemic Load, and Dietary Fiber in Relation to Risk of Stroke in Women" Am. J. Epidemiol., May 15, 2005; 161(10): 995 - 995. [Full Text] [PDF] |
||||
![]() |
B. Bartling, H.-S. Hofmann, B. Weigle, R.-E. Silber, and A. Simm Down-regulation of the receptor for advanced glycation end-products (RAGE) supports non-small cell lung carcinoma Carcinogenesis, February 1, 2005; 26(2): 293 - 301. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Howes, Y. Liu, J. L. Dunaief, A. Milam, J. M. Frederick, A. Marks, and W. Baehr Receptor for Advanced Glycation End Products and Age-Related Macular Degeneration Invest. Ophthalmol. Vis. Sci., October 1, 2004; 45(10): 3713 - 3720. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Marx, D. Walcher, N. Ivanova, K. Rautzenberg, A. Jung, R. Friedl, V. Hombach, R. de Caterina, G. Basta, M.-P. Wautier, et al. Thiazolidinediones Reduce Endothelial Expression of Receptors for Advanced Glycation End Products Diabetes, October 1, 2004; 53(10): 2662 - 2668. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Basta, A. M. Schmidt, and R. De Caterina Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes Cardiovasc Res, September 1, 2004; 63(4): 582 - 592. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lu, J. C. He, W. Cai, H. Liu, L. Zhu, and H. Vlassara Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells PNAS, August 10, 2004; 101(32): 11767 - 11772. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-L. Wautier and A. M. Schmidt Protein Glycation: A Firm Link to Endothelial Cell Dysfunction Circ. Res., August 6, 2004; 95(3): 233 - 238. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Mamputu and G. Renier Advanced glycation end-products increase monocyte adhesion to retinal endothelial cells through vascular endothelial growth factor-induced ICAM-1 expression: inhibitory effect of antioxidants J. Leukoc. Biol., June 1, 2004; 75(6): 1062 - 1069. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Greenway, R. J. van Suylen, G. Du Marchie Sarvaas, E. Kwan, N. Ambartsumian, E. Lukanidin, and M. Rabinovitch S100A4/Mts1 Produces Murine Pulmonary Artery Changes Resembling Plexogenic Arteriopathy and Is Increased in Human Plexogenic Arteriopathy Am. J. Pathol., January 1, 2004; 164(1): 253 - 262. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Foell, D. Kane, B. Bresnihan, T. Vogl, W. Nacken, C. Sorg, O. FitzGerald, and J. Roth Expression of the pro-inflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis Rheumatology, November 1, 2003; 42(11): 1383 - 1389. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Cipollone, A. Iezzi, M. Fazia, M. Zucchelli, B. Pini, C. Cuccurullo, D. De Cesare, G. De Blasis, R. Muraro, R. Bei, et al. The Receptor RAGE as a Progression Factor Amplifying Arachidonate-Dependent Inflammatory and Proteolytic Response in Human Atherosclerotic Plaques: Role of Glycemic Control Circulation, September 2, 2003; 108(9): 1070 - 1077. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhang, A. Zalewski, Y. Liu, T. Mazurek, S. Cowan, J. L. Martin, S. M. Hofmann, H. Vlassara, and Y. Shi Diabetes-Induced Oxidative Stress and Low-Grade Inflammation in Porcine Coronary Arteries Circulation, July 29, 2003; 108(4): 472 - 478. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Basta, L. Venneri, G. Lazzerini, E. Pasanisi, M. Pianelli, N. Vesentini, S. Del Turco, C. Kusmic, and E. Picano In vitro modulation of intracellular oxidative stress of endothelial cells by diagnostic cardiac ultrasound Cardiovasc Res, April 1, 2003; 58(1): 156 - 161. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Laakso and J. Kuusisto Diabetology for cardiologists Eur. Heart J. Suppl., January 1, 2003; 5(suppl_B): B5 - B13. [Abstract] [PDF] |
||||
![]() |
R. De Caterina and C. Manes Inflammation in early atherogenesis: impact of ACE inhibition Eur. Heart J. Suppl., January 1, 2003; 5(suppl_A): A15 - A24. [Abstract] [PDF] |
||||
![]() |
F. L Ruberg and J. Loscalzo Prothrombotic determinants of coronary atherothrombosis Vascular Medicine, November 1, 2002; 7(4): 289 - 299. [Abstract] [PDF] |
||||
![]() |
W. Che, N. Lerner-Marmarosh, Q. Huang, M. Osawa, S. Ohta, M. Yoshizumi, M. Glassman, J.-D. Lee, C. Yan, B. C. Berk, et al. Insulin-Like Growth Factor-1 Enhances Inflammatory Responses in Endothelial Cells: Role of Gab1 and MEKK3 in TNF-{alpha}-Induced c-Jun and NF-{kappa}B Activation and Adhesion Molecule Expression Circ. Res., June 14, 2002; 90(11): 1222 - 1230. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |